DAM
BHVN

DLD Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

DLD Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,000
Closed -$3.64M – 228
2022
Q2 		$3.64M Buy
+25,000
New +$3.64M 0.26% 58